HIF1A and benign prostatic hyperplasia: Conversely, natural HIF-1α inhibitors, such as ascorbate and curcumin, have been reported to attenuate EMT and prostate hyperplasia both in vivo and in vitro, therefore providing a promising target for preventing the switch from prostatitis to BPH or PCa.